☆ 4.6 Review

Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?

CANCERS (2023)

Related references

Note: Only part of the references are listed.
Review Oncology

Diagnostic performance of MRI, SPECT, and PET in detecting renal cell carcinoma: a systematic review and meta-analysis

Qihua Yin et al.

Summary: This study compares the performance of MRI, SPECT, and PET in the detection of RCC in humans through a meta-analysis. The results show that MRI and PET/CT have better diagnostic value for detecting RCC, with MRI being superior in the diagnosis of primary RCC.

BMC CANCER (2022)

Add to Collection
Article Oncology

Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy

Yaopeng Qiu et al.

Summary: The presence of circulating tumor cell (CTC)-associated white blood cell clusters (CTC-WBC clusters) is associated with poor prognosis in patients with gastric cancer (GC) after radical gastrectomy.

EJSO (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells

Dannel Yeo et al.

Summary: This review summarizes the data on the utility of CTCs in PDAC and discusses the molecular profiling and culture methods of CTCs. CTCs have the potential to be used in screening, early diagnosis, prognostic assessment, and personalized management of PDAC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Article Urology & Nephrology

Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitors

Bo-Han Chen et al.

Summary: This study investigates the relationship between the expression of programmed cell death ligand 1 (PD-L1) on circulating tumor cells and the efficacy of immune checkpoint inhibitors in patients with clear cell renal cell carcinoma. The results show that PD-L1 expression on circulating tumor cells is not correlated with PD-L1 expression in primary tumors. However, patients with PD-L1-positive circulating tumor cells have a higher disease control rate during treatment with programmed cell death protein 1 (PD-1) inhibitors. The study also suggests that changes in circulating tumor cell numbers and PD-L1-positive circulating tumor cell counts can be used to monitor therapeutic response.

INTERNATIONAL JOURNAL OF UROLOGY (2022)

Add to Collection
Review Genetics & Heredity

Circulating tumor cells in colorectal cancer in the era of precision medicine

Mingchao Hu et al.

Summary: Colorectal cancer is a leading cause of cancer-related morbidity and mortality globally. Circulating tumor cells (CTCs) have the potential to play a significant role in the early diagnosis, prognosis, and treatment response prediction of CRC. Efficient CTC isolation platforms have been developed for capturing and identifying CTCs.

JOURNAL OF MOLECULAR MEDICINE-JMM (2022)

Add to Collection
Article Oncology

Prognostic value of circulating tumor cells and immune-inflammatory cells in patients with renal cell carcinoma

Yibing Guan et al.

Summary: By analyzing data from the GEO database and clinical statistics, we found correlations among circulating tumor cells (CTCs), platelets, and immune-inflammatory cells in patients with renal cell carcinoma (RCC). These correlations can be used to predict the risk of postoperative metastasis, and staging and the monocyte-to-neutrophil ratio (MNR) can serve as accurate prognostic indicators for condition monitoring.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Add to Collection
Review Oncology

The Role of Dielectrophoresis for Cancer Diagnosis and Prognosis

Giorgio Ivan Russo et al.

Summary: Dielectrophoresis (DEP) is a label-free cell manipulation technique based on electrical differences that can be applied to liquid biopsies for cancer diagnosis and prognosis. DEP offers advantages in terms of cost, yield, and specificity compared to other technologies, but further technical and clinical development is still needed.

CANCERS (2022)

Add to Collection
Article Cell Biology

Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients

Adriana Carneiro et al.

Summary: Gastrointestinal cancers, such as colorectal cancer and gastric cancer, have high morbidity rates worldwide. Epithelial-to-mesenchymal transition (EMT) in cancer promotes the formation of circulating tumor cells (CTCs), which are important for cancer diagnosis and monitoring. However, current CTC isolation approaches are not ideal for capturing EMT or mesenchymal CTCs.

CELLS (2022)

Add to Collection
Article Biology

Potential Use of CTCs as Biomarkers in Renal Cancer Patients

Joanna Bialek et al.

Summary: We demonstrated that the CellCollector is an appropriate tool for detecting CTCs in RCC patients. We examined the expression levels of EpCAM and MUC1 in RCC tissues and cell lines and analyzed the detection rate of CTCs in blood samples using an anti-EpCAM antibody-covered wire. The use of this combination of antibodies allowed us to classify patients with lung metastasis.

LIFE-BASEL (2022)

Add to Collection
Article Oncology

Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma

Matthew Bootsma et al.

Summary: In this study, liquid biopsies were used to analyze CTC enumeration and the HLA I to PD-L1 ratio in metastatic renal cell carcinoma (mRCC) patients. The results showed that changes in CTC abundance and the HP ratio were significantly associated with treatment response and overall survival. These findings provide potential biomarkers to predict and monitor response to immunotherapy in mRCC.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection
Review Oncology

Models of Renal Cell Carcinoma Used to Investigate Molecular Mechanisms and Develop New Therapeutics

Daniel D. Shapiro et al.

Summary: Modeling renal cell carcinoma is crucial for understanding tumor characteristics and therapeutic mechanisms. Various in vitro and in vivo models have been developed to mimic the tumor and its microenvironment, and researchers must thoroughly understand the advantages and limitations of these models to select appropriate ones for their research questions.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection
Article Andrology

A preliminary study on the association between epithelial-mesenchymal transition and circulating tumor cells in renal cell carcinoma

Huansheng Wang et al.

Summary: Our results indirectly confirmed the occurrence of EMT in the formation of CTCs by comparing and analyzing the expression of CK8/18/19 and EpCAM in renal cancer tissues and the detection results of CTCs.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2022)

Add to Collection
Article Oncology

Size-based isolation and detection of renal carcinoma cells from whole blood

Roger De Alwis et al.

Summary: This study developed a liquid biopsy platform for isolation of renal cell carcinoma (RCC) circulating tumor cells (CTCs) from whole blood. The RCC CTCs could be detected and identified using molecular techniques, and subtype-specific transcripts were identified to distinguish different subtypes of RCC.

MOLECULAR AND CLINICAL ONCOLOGY (2022)

Add to Collection
Review Urology & Nephrology

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours

Holger Moch et al.

Summary: The fifth edition of the WHO classification of urogenital tumours has made significant revisions, including the introduction of molecular-driven renal tumour classification and simplification of the morphologic classification of penile squamous cell carcinomas. A new chapter has also been added for tumours of the scrotum. The main nomenclature for testicular tumours remains the same, but there have been changes in some terms.

EUROPEAN UROLOGY (2022)

Add to Collection
Article Oncology

A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study

Takayuki Arai et al.

Summary: This study reviewed the treatment results and prognosis of postoperative RCC patients, and found that late recurrence is not uncommon and a significant proportion of patients are lost to long-term follow-up. Older age, histological type, and no recurrence were identified as significant risk factors for lost follow-up.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection
Article Oncology

Multiparametric Phenotyping of Circulating Tumor Cells for Analysis of Therapeutic Targets, Oncogenic Signaling Pathways and DNA Repair Markers

Stephanie Staudte et al.

Summary: Detection of circulating tumor cells (CTCs) has been established as an independent prognostic marker in solid cancer. This study evaluated the suitability of the Arnnis brand ImageStream X MkII (ISX) imaging flow cytometer for protein expression analysis and treatment monitoring in CTCs. The results showed that the ISX-based protocol was sensitive and specific in detecting phospho-EGFR and gamma H2AX foci in CTCs, and allowed assessment of protein expression heterogeneity within the CTC population.

CANCERS (2022)

Add to Collection
Article Oncology

Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept

Xavier Rousset et al.

Summary: The study established a chicken CAM model to analyze the dissemination and metastasis mechanisms of human tumor cells effectively, providing a novel attempt towards personalized medicine.

CANCERS (2022)

Add to Collection
Review Biochemistry & Molecular Biology

Circulating tumor cells in the early detection of human cancers

Zixin Feng et al.

Summary: Cancer is a severe disease with high morbidity and mortality globally. Early detection is crucial for successful treatment, but remains challenging. Various screening methods are widely used, but each has limitations and potential harms. Liquid biopsy is a convenient and non-invasive approach for early tumor screening and diagnosis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Add to Collection
Review Oncology

Emerging Technologies for the Detection of Cancer Micrometastasis

Xuqing Mao et al.

Summary: Surgery is the most efficient way to treat tumors, but many cancer patients still have a poor prognosis even after undergoing radical excision at an early stage. Micrometastasis, an undetected condition, can lead to the failure of initial treatment. Therefore, preoperative and intraoperative detection of micrometastasis is crucial for cancer patients' prognosis and optimal therapy. Efforts have been made to develop more effective detection technologies in order to achieve this goal.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2022)

Add to Collection
Review Urology & Nephrology

Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature

Louise Geertsen et al.

Summary: There has been increasing interest in the potential of liquid biopsies and systematic biomarkers in the diagnosis and management of kidney cancer. Studies demonstrate that the level of ctDNA in RCC appears to be low, and sensitive methods are required for its detection in this disease.

EUROPEAN UROLOGY OPEN SCIENCE (2022)

Add to Collection
Article Biology

Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma

Pei-Jhang Chiang et al.

Summary: This study demonstrated that PD-L1-positive circulating tumor cells (CTCs) can serve as a predictor of treatment response to PD-L1 inhibitors and are associated with disease control rates. Dynamic changes in PD-L1-positive CTCs during therapy were found to be predictive factors of immunotherapy response and prognostic factors of disease control.

BIOLOGY-BASEL (2021)

Add to Collection
Article Oncology

Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients

Pauline A. J. Mendelaar et al.

Summary: The study analyzed the size characteristics of CTCs in different cancer patients and found significant size differences among different tumor types, with CTCs being significantly smaller than cell line tumor cells. This has implications for designing and optimizing size-based isolation methods for CTCs.

MOLECULAR ONCOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

Shaan Dudani et al.

Summary: This study found that patterns of metastasis vary between histologic subtypes of metastatic RCC and are associated with overall survival. The data highlight the clinical and biological variability between histologic subtypes and suggest that patterns of metastasis may reflect differences in underlying disease biology. Further research is encouraged to investigate differences in immune, molecular, and genetic profiles between metastatic sites and histologic subtypes.

JAMA NETWORK OPEN (2021)

Add to Collection
Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Routes to diagnosis and missed opportunities in the detection of renal cancer

A. J. Bradley et al.

Summary: The most common route to diagnose renal cancer is through incidental detection of a mass. Younger patients are more likely to be incidentally diagnosed, and these tumors are smaller at diagnosis. Additionally, a certain proportion of patients have missed opportunities for diagnosis, but the clinical impact of these missed opportunities remains uncertain.

CLINICAL RADIOLOGY (2021)

Add to Collection
Article Oncology

Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma

Rory M. Bade et al.

Summary: This study used ccRCC-specific markers to identify CTCs from patients with metastatic ccRCC, and found that CTC enumeration and PD-L1 and HLA-I expression correlated with disease progression and treatment response. The longitudinal evaluation showed the potential for CTC enumeration to serve as a pharmacodynamic biomarker, but further evaluation of phenotypic heterogeneity among CTCs is needed to better understand the clinical utility of this new biomarker.

MOLECULAR ONCOLOGY (2021)

Add to Collection
Article Oncology

Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma

Brusabhanu Nayak et al.

Summary: In patients with metastatic renal cell carcinoma (mRCC), CTC positivity at baseline was associated with lower progression-free survival rate and poor response to TKI therapy. Baseline CTC detection could be an important prognostic factor and significant predictor of treatment response in mRCC patients.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Add to Collection
Review Oncology

A Review of Circulating Tumour Cell Enrichment Technologies

Amelia J. Rushton et al.

Summary: Circulating tumor cells (CTCs) are shed from tumors into the bloodstream and have the potential to provide important insights into cancer detection and monitoring. CellSearch is the only FDA-approved technology for determining the prognosis of patients with advanced breast, prostate, and colorectal cancers, but new label-free enrichment technologies are emerging.

CANCERS (2021)

Add to Collection
Review Oncology

Circulating tumor cell detection methods in renal cell carcinoma: A systematic review

Tito Palmela Leita et al.

Summary: CTCs have potential as a biomarker for RCC, but evidence is limited and detection methods lack standardization. Various detection platforms and molecular markers have been used, but none is proven superior. Despite correlations with staging and survival outcomes, CTC research in RCC is still in an exploratory phase.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Add to Collection
Article Oncology

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma

Kate Glennon et al.

Summary: Renal cell carcinoma (RCC) poses challenges in identifying high-risk patients for relapse or metastasis due to lack of reliable clinical biomarkers. Our study developed an improved assay to capture prognostic genomic biomarkers in RCC ctDNA, showing reliable performance in detecting gene mutations in tumor DNA isolated from plasma and extracellular vesicles. This study presents an RCC-appropriate sequencing assay and workflow for ctDNA analysis, demonstrating the feasibility of detecting tumor-specific mutations in liquid biopsy in RCC patients.

CANCERS (2021)

Add to Collection
Article Oncology

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer

Pelin Balcik-Ercin et al.

Summary: Metastasis is a complex and not fully understood process in cancer, where circulating tumor cells (CTCs) play a crucial role. CTCs possess a unique ability to transition between epithelial and mesenchymal states, known as epithelial-to-mesenchymal plasticity (EMP), which aids in their metastatic potential. This study focuses on the EMP phenotype of colon CTC lines, showing that these cells have minimal mesenchymal features but exhibit an increase in mesenchymal-epithelial transition (MET) markers, suggesting a quick reversion to the epithelial state for successful metastasis.

CANCERS (2021)

Add to Collection
Article Oncology

Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer

Minji Lim et al.

Summary: CTC clusters with mesenchymal characteristics and platelet marker expression are highly correlated with poor prognosis in patients with unresectable pancreatic cancer. Most CTCs in these patients are cloaked with platelets and the increase in CTC clusters is positively correlated with rapid disease progression, indicating their potential as prognostic markers and a target for personalized disease management.

CANCERS (2021)

Add to Collection
Review Oncology

Detection and clinical significance of circulating tumor cells in colorectal cancer

Miao Jiang et al.

Summary: Liquid biopsy is a promising minimally invasive method for early colorectal cancer detection, sampling circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA (miRNA) and extracellular vesicles (EVs) to provide information on tumor dynamics.

BIOMARKER RESEARCH (2021)

Add to Collection
Article Oncology

The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma

Yibing Guan et al.

Summary: Research shows that CTC-WBC clusters are related to prognosis in renal cell carcinoma patients. Total CTCs, pathology type, and CTC-WBC clusters can be used as prognostic indicators for MFS, while total CTCs and solid tumor diameter are prognostic indicators for OS.

BMC CANCER (2021)

Add to Collection
Review Genetics & Heredity

Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells

Maxim E. Menyailo et al.

Summary: Metastasis, the spread of tumor cells from the primary site to other parts of the body, is a major cause of cancer-related deaths. Circulating tumor cells (CTCs) with stem-like and hybrid epithelial-mesenchymal phenotypes can evade immune surveillance and exhibit increased therapy resistance, contributing to the negative prognosis associated with distant metastasis. Targeting the molecular and cellular characteristics of metastatic CTCs, including CTC clusters, may hold promise for preventing metastasis and improving therapeutic outcomes.

MOLECULAR DIAGNOSIS & THERAPY (2021)

Add to Collection
Article Oncology

Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies

Zhaoli Tan et al.

Summary: The study investigates the role of PD-L1 expression on circulating tumor cells in predicting and monitoring response to PD-1/PD-L1 blockade immunotherapies in advanced cancer patients. Results suggest that PD-L1-high-expression CTCs serve as a predictive biomarker and prognostic factor in patients treated with anti-PD-1/PD-L1 monoclonal antibodies, indicating its potential as a clinical biomarker for immunotherapy.

ONCOLOGIST (2021)

Add to Collection
Article Multidisciplinary Sciences

Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis

Hui Jiang et al.

Summary: This meta-analysis included 11 eligible studies with a total of 1,062 BC patients. Overall analysis showed that CTC-positive patients had poorer survival and more aggressive disease progression than CTC-negative patients. Subgroup analyses confirmed that the presence of CTCs predicted a high risk of mortality and disease progression in most subgroups.

PLOS ONE (2021)

Add to Collection
Article Oncology

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma

Jinbo Song et al.

Summary: This study aimed to analyze the potential value of circulating tumor cells (CTCs) and the proliferative marker Ki-67 in the diagnosis of renal cell carcinoma (RCC). The results showed a significant decrease in CTC counts after surgery, suggesting that CTCs could serve as potential biomarkers for the diagnosis and prognosis of RCC.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)

Add to Collection
Editorial Material Urology & Nephrology

Renal cancer: overdiagnosis and overtreatment

Giuseppe Rosiello et al.

WORLD JOURNAL OF UROLOGY (2021)

Add to Collection
Article Multidisciplinary Sciences

Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

Yun-Fan Sun et al.

Summary: This study used single-cell RNA sequencing to analyze circulating tumor cells from liver cancer patients, revealing that the transcriptional dynamics of CTCs are associated with stress response, cell cycle, and immune evasion signaling. Additionally, it was identified that CCL5 plays a crucial role in immune evasion of CTCs.

NATURE COMMUNICATIONS (2021)

Add to Collection
Article Urology & Nephrology

CTCs detection from intraoperative salvaged blood in RCC-IVC thrombus patients by negative enrichment and iFISH identification: a preliminary study

Xiaoqing Zhang et al.

Summary: This study analyzed the effect of IOCS-LDF on eliminating circulating tumor cells in 5 RCC-IVC thrombus patients. Results showed a decrease in CTC numbers after IOCS-LDF treatment, indicating the potential of IOCS-LDF as a promising way to reduce allogeneic product transfusion. Further conclusions require larger sample sizes and long-term follow-up studies for patient prognosis.

BMC UROLOGY (2021)

Add to Collection
Article Oncology

Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models

Sara Hassan et al.

Summary: Metastasis of prostate cancer is responsible for most deaths, with CTCs playing a crucial role. This study molecularly characterized CTCs from prostate cancer patient-derived xenografts, revealing high heterogeneity and caution required in CTC analysis. The findings highlight the complexity in CTC isolation and classification, underscoring the importance of epithelial-mesenchymal plasticity in cancer progression and metastasis.

CANCERS (2021)

Add to Collection
Review Oncology

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer

Bianca C. T. Flores et al.

Summary: Prostate cancer presents with high variability in clinical outcomes, making diagnosis and treatment challenging. Studies suggest that using DNA methylation and circulating tumor cells as biomarkers can improve diagnostic and treatment decisions in prostate cancer patients.

CANCERS (2021)

Add to Collection
Article Oncology

A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy

Sung Han Kim et al.

Summary: This study compared the cancer-specific survival and overall survival of patients with non-metastatic renal cell carcinoma who experienced disease recurrence in different scenarios. The findings indicated that the group with local recurrence had the worst survival outcomes compared to the other groups.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Letter Oncology

Tri-modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell-free DNA using machine learning algorithm

Jiyoon Bu et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Circulating tumor cells: biology and clinical significance

Danfeng Lin et al.

Summary: CTCs, tumor cells that have sloughed off the primary tumor and circulate in the blood, have potential for identifying targets against cancer metastasis. Detecting these rare CTCs in the massive pool of blood cells is challenging, but emerging detection technologies have deepened our understanding of their biology and clinical applications. Molecular markers, such as epithelial cell adhesion molecule, play a key role in CTC detection, with properties like epithelial-to-mesenchymal transition and stemness indicating increased metastatic capacity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection
Article Oncology

Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma

Nobuhiro Haga et al.

ANNALS OF SURGICAL ONCOLOGY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression

Vera Cappelletti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis

Nicola Aceto

BIOMEDICAL JOURNAL (2020)

Add to Collection
Article Multidisciplinary Sciences

Renal carcinoma CD105-/CD44-cells display stem-like properties in vitro and form aggressive tumors in vivo

M. Fiedorowicz et al.

SCIENTIFIC REPORTS (2020)

Add to Collection
Review Genetics & Heredity

Tracking cancer progression: from circulating tumor cells to metastasis

Francesc Castro-Giner et al.

GENOME MEDICINE (2020)

Add to Collection
Article Medicine, General & Internal

Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus A STROBE-compliant study

Liyuan Ge et al.

MEDICINE (2020)

Add to Collection
Article Biotechnology & Applied Microbiology

Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes

Junyi Hu et al.

MOLECULAR THERAPY (2020)

Add to Collection
Article Medicine, General & Internal

Detection of Circulating Tumor Cells in Renal Cell Carcinoma: Disease Stage Correlation and Molecular Characterization

Petr Klezl et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection
Review Oncology

The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance

Hassan Dianat-Moghadam et al.

CANCERS (2020)

Add to Collection
Article Biophysics

Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application

Jiyoon Bu et al.

BIOSENSORS & BIOELECTRONICS (2020)

Add to Collection
Article Urology & Nephrology

Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH)

Dongxu Tian et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)

Add to Collection
Review Oncology

Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities

Zeina Habli et al.

CANCERS (2020)

Add to Collection
Article Genetics & Heredity

Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis

Yibing Guan et al.

BMC MEDICAL GENOMICS (2020)

Add to Collection
Article Urology & Nephrology

Imaging for Metastatic Renal Cell Carcinoma

Soumya V. L. Vig et al.

UROLOGIC CLINICS OF NORTH AMERICA (2020)

Add to Collection
Article Urology & Nephrology

Essential Research Priorities in Renal Cancer: A Modified Delphi Consensus Statement

Sabrina H. Rossi et al.

EUROPEAN UROLOGY FOCUS (2020)

Add to Collection
Article Oncology

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up

Tae-Min Kim et al.

BMC CANCER (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Analysis of the Circulating Tumor Cell Capture Ability of a Slit Filter-Based Method in Comparison to a Selection-Free Method in Multiple Cancer Types

Hidenori Takagi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection
Article Medicine, Research & Experimental

Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma

Emma Andersson-Evelonn et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection
Review Oncology

Epidemiology of Renal Cell Carcinoma

Sandeep Anand Padala et al.

WORLD JOURNAL OF ONCOLOGY (2020)

Add to Collection
Review Urology & Nephrology

Epidemiology of Renal Cell Carcinoma

Umberto Capitanio et al.

EUROPEAN UROLOGY (2019)

Add to Collection
Article Oncology

Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

Zhe Su et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection
Article Multidisciplinary Sciences

Detection of circulating tumor cells in blood by shell-isolated nanoparticle - enhanced Raman spectroscopy (SHINERS) in microfluidic device

K. Nicinski et al.

SCIENTIFIC REPORTS (2019)

Add to Collection
Article Oncology

Cooperation Between the Inflammation and Coagulation Systems Promotes the Survival of Circulating Tumor Cells in Renal Cell Carcinoma Patients

Li Wen et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection
Article Medicine, General & Internal

Development of a Highly Sensitive Technique for Capturing Renal Cell Cancer Circulating Tumor Cells

Michio Naoe et al.

DIAGNOSTICS (2019)

Add to Collection
Article Oncology

Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC

Zhen-Long Wang et al.

CANCER BIOLOGY & THERAPY (2019)

Add to Collection
Article Oncology

Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies

Zhenlong Ye et al.

CANCER BIOLOGY & THERAPY (2019)

Add to Collection
Article Gastroenterology & Hepatology

Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice

Xiao-Hui Zhao et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection
Article Oncology

Noninvasive circulating tumor cell and urine cellular XPC (rs2228001, A2815C) and XRCC1 (rs25487, G1196A) polymorphism detection as an effective screening panel for genitourinary system cancers

Cen Wu et al.

TRANSLATIONAL CANCER RESEARCH (2019)

Add to Collection
Review Oncology

The biology and clinical potentialof circulating tumor cells

Taja Lozar et al.

RADIOLOGY AND ONCOLOGY (2019)

Add to Collection
Article Oncology

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

Andrew A. Davis et al.

BREAST CANCER RESEARCH (2019)

Add to Collection
Article Radiology, Nuclear Medicine & Medical Imaging

Renal cancer at unenhanced CT: imaging features, detection rates, and outcomes

Stacy D. O'Connor et al.

ABDOMINAL RADIOLOGY (2018)

Add to Collection
Review Pharmacology & Pharmacy

Clinical indications for, and the future of, circulating tumor cells

Dominic H. Moon et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Add to Collection
Article Biochemistry & Molecular Biology

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Samra Turajlic et al.

CELL (2018)

Add to Collection
Article Biochemistry & Molecular Biology

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Samra Turajlic et al.

CELL (2018)

Add to Collection
Article Medicine, General & Internal

The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma

Naoya Nagaya et al.

INTERNAL MEDICINE (2018)

Add to Collection
Article

Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma

Lucile Broncy et al.

Oncotarget (2018)

Add to Collection
Article Urology & Nephrology

Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma

Menglin Bai et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)

Add to Collection
Article Multidisciplinary Sciences

Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients' Blood using Hydrogel-based Cell Block Formation

Yoon-Tae Kang et al.

SCIENTIFIC REPORTS (2018)

Add to Collection
Article Chemistry, Multidisciplinary

Candle soot-templated silica nanobiointerface chip for detecting circulating tumour cells from patients with urologic malignancies

Tianying Xing et al.

RSC ADVANCES (2018)

Add to Collection
Article Biochemical Research Methods

Proportion of circulating tumor cell clusters increases during cancer metastasis

Yuanzhen Suo et al.

CYTOMETRY PART A (2017)

Add to Collection
Article Oncology

Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells

Xiuwen Guan et al.

ONCOTARGET (2016)

Add to Collection
Article Oncology

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients

Shijie Liu et al.

ONCOTARGET (2016)

Add to Collection
Article Oncology

Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer

Lori E. Lowes et al.

ONCOTARGET (2016)

Add to Collection
Article Multidisciplinary Sciences

Circulating Tumor Cell Composition in Renal Cell Carcinoma

Ivonne Nel et al.

PLOS ONE (2016)

Add to Collection
Article Multidisciplinary Sciences

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells

Mohammed I. Khan et al.

PLOS ONE (2016)

Add to Collection
Article Multidisciplinary Sciences

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers

Shiyang Wu et al.

PLOS ONE (2015)

Add to Collection
Review Oncology

Cancer Metastases: Early Dissemination and Late Recurrences

Sten Friberg et al.

CANCER GROWTH AND METASTASIS (2015)

Add to Collection
Article Multidisciplinary Sciences

Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood

Frank A. W. Coumans et al.

PLOS ONE (2013)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.